Thomas Steck

978 total citations
26 papers, 682 citations indexed

About

Thomas Steck is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Immunology. According to data from OpenAlex, Thomas Steck has authored 26 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 9 papers in Reproductive Medicine and 7 papers in Immunology. Recurrent topics in Thomas Steck's work include Reproductive Biology and Fertility (6 papers), Reproductive System and Pregnancy (6 papers) and Reproductive Health and Technologies (3 papers). Thomas Steck is often cited by papers focused on Reproductive Biology and Fertility (6 papers), Reproductive System and Pregnancy (6 papers) and Reproductive Health and Technologies (3 papers). Thomas Steck collaborates with scholars based in Germany, United States and France. Thomas Steck's co-authors include J. Dietl, S. Bussen, Martin K. Oehler, J. Martius, Marc Sütterlin, Martin Faßnacht, Ralf Giess, Carole Ober, Wiebke Arlt and Bruno Allolio and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Human Reproduction and Clinical Endocrinology.

In The Last Decade

Thomas Steck

25 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Steck Germany	15	240	234	233	155	149	26	682
S. Bussen Germany	13	180 0.8×	170 0.7×	174 0.7×	197 1.3×	171 1.1×	37	621
K. W. Hancock United Kingdom	16	191 0.8×	231 1.0×	215 0.9×	210 1.4×	73 0.5×	46	746
Saffet Dılek Türkiye	17	194 0.8×	134 0.6×	73 0.3×	221 1.4×	101 0.7×	43	656
Katharina Walch Austria	17	472 2.0×	302 1.3×	182 0.8×	196 1.3×	57 0.4×	46	825
Fausta Beneventi Italy	18	100 0.4×	185 0.8×	154 0.7×	281 1.8×	97 0.7×	57	691
Erbil Doğan Türkiye	17	511 2.1×	278 1.2×	108 0.5×	337 2.2×	68 0.5×	49	875
Joan Rasor United States	10	217 0.9×	398 1.7×	152 0.7×	167 1.1×	75 0.5×	14	792
Michael Feinman United States	13	389 1.6×	333 1.4×	335 1.4×	186 1.2×	46 0.3×	27	829
Raymond W. Ke United States	15	413 1.7×	438 1.9×	104 0.4×	116 0.7×	68 0.5×	24	776
Sabahattin Altunyurt Türkiye	15	140 0.6×	150 0.6×	67 0.3×	232 1.5×	47 0.3×	49	579

Countries citing papers authored by Thomas Steck

Since Specialization

Citations

This map shows the geographic impact of Thomas Steck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Steck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Steck more than expected).

Fields of papers citing papers by Thomas Steck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Steck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Steck. The network helps show where Thomas Steck may publish in the future.

Co-authorship network of co-authors of Thomas Steck

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Steck. A scholar is included among the top collaborators of Thomas Steck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Steck. Thomas Steck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koensgen, Dominique, Dirk Stengel, Antje Belau, et al.. (2007). Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study. Cancer Chemotherapy and Pharmacology. 62(3). 393–400. 14 indexed citations

Kretzschmar, Albrecht, Salah‐Eddin Al‐Batran, Manfred Kindler, et al.. (2007). Rapid and Sustained Influence of Intravenous Zoledronic Acid on Course of Pain and Analgesics Consumption in Patients with Cancer with Bone Metastases: A Multicenter Open-Label Study Over 1 Year. PubMed. 4(4). 203–210. 14 indexed citations

Steck, Thomas, et al.. (2005). Pregnancy associated hormones modulate the cytokine production but not the phenotype of PBMC-derived human dendritic cells. European Journal of Obstetrics & Gynecology and Reproductive Biology. 122(1). 85–94. 47 indexed citations

Bussen, S., et al.. (2004). Semen parameters in patients with unilateral testicular cancer compared to patients with other malignancies. Archives of Gynecology and Obstetrics. 269(3). 196–198. 13 indexed citations

Sütterlin, Marc, S. Bussen, Lorenz Rieger, J. Dietl, & Thomas Steck. (2004). Reply to ‘Letter to the Editor’ by Bor MV “Do we have any good reason to suggest restricting the use of oral contraceptives in women with pre-existing Vitamin B12 deficiency?” Contraceptive use in women with pre-existing Vitamin B12 deficiency. European Journal of Obstetrics & Gynecology and Reproductive Biology. 115(2). 241–242.

Steck, Thomas, et al.. (2003). Leukaemia inhibitory factor (LIF) gene mutations in women with unexplained infertility and recurrent failure of implantation after IVF and embryo transfer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 112(1). 69–73. 78 indexed citations

Sütterlin, Marc, S. Bussen, Lorenz Rieger, J. Dietl, & Thomas Steck. (2003). Serum folate and Vitamin B12 levels in women using modern oral contraceptives (OC) containing 20 μg ethinyl estradiol. European Journal of Obstetrics & Gynecology and Reproductive Biology. 107(1). 57–61. 33 indexed citations

Girschick, G, et al.. (2003). Umbilical endometriosis without previous pelvic surgery: a case report. Archives of Gynecology and Obstetrics. 267(4). 258–260. 28 indexed citations

Faßnacht, Martin, et al.. (2001). Octreotide LAR^® treatment throughout pregnancy in an acromegalic woman. Clinical Endocrinology. 55(3). 411–415. 56 indexed citations

10.

Bussen, S., Thomas Steck, & J. Dietl. (2000). Increased prevalence of thyroid antibodies in euthyroid women with a history of recurrent in-vitro fertilization failure. Human Reproduction. 15(3). 545–548. 83 indexed citations

11.

Steck, Thomas, et al.. (1999). Evaluation of a cut-off value for sperm motility after different hours of incubation to select the suitable reproductive technology (IVF or ICSI).. PubMed. 78(4). 326–31. 11 indexed citations

12.

Steck, Thomas, et al.. (1999). Evaluation of a cut‐off value for sperm motility after different hours of incubation to select the suitable reproductive technology (IVF or ICSI). Acta Obstetricia Et Gynecologica Scandinavica. 78(4). 326–331. 3 indexed citations

13.

Bussen, S., Marc Sütterlin, & Thomas Steck. (1998). Plasma renin activity and aldosterone serum concentration are decreased in severe preeclampsia but not in the HELLP‐syndrome. Acta Obstetricia Et Gynecologica Scandinavica. 77(6). 609–613. 18 indexed citations

14.

Martius, J., et al.. (1998). Risk factors associated with preterm (<37+0 weeks) and early preterm birth (<32+0 weeks): univariate and multivariate analysis of 106 345 singleton births from the 1994 statewide perinatal survey of Bavaria. European Journal of Obstetrics & Gynecology and Reproductive Biology. 80(2). 183–189. 91 indexed citations

15.

Bussen, S., et al.. (1997). Relationship of bacteriological characteristics to semen indices and its influence on fertilization and pregnancy rates after IVF. Acta Obstetricia Et Gynecologica Scandinavica. 76(10). 964–968. 15 indexed citations

16.

Bussen, S. & Thomas Steck. (1997). Thyroid antibodies and their relation to antithrombin antibodies, anticardiolipin antibodies and lupus anticoagulant in women with recurrent spontaneous abortions (antithyroid, anticardiolipin and antithrombin autoantibodies and lupus anticoagulant in habitual aborters). European Journal of Obstetrics & Gynecology and Reproductive Biology. 74(2). 139–143. 49 indexed citations

17.

Steck, Thomas, Katrin van der Ven, Joanne Y.H. Kwak, Alan E. Beer, & Carole Ober. (1995). HLA-DQA1 and HLA-DQB1 haplotypes in aborted fetuses and couples with recurrent spontaneous abortion. Journal of Reproductive Immunology. 29(2). 95–104. 16 indexed citations

18.

Steck, Thomas, et al.. (1995). Erhebung zur Prävalenz von prä- und perimenstruellen Symptomen am weiblichen Personal eines Universitätsklinikums. Gyn�kologisch-geburtshilfliche Rundschau. 35(4). 199–208. 3 indexed citations

19.

Ober, Carole, Thomas Steck, Katrin van der Ven, et al.. (1993). MHC class II compatibility in aborted fetuses and term infants of couples with recurrent spontaneous abortion. Journal of Reproductive Immunology. 25(3). 195–207. 45 indexed citations

20.

Ober, Carole, et al.. (1992). Increased risk for polycystic ovary syndrome associated with human leukocyte antigen DQA1*0501. American Journal of Obstetrics and Gynecology. 167(6). 1803–1806. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact